Novartis Pharma B.V.

Location

Noord-Holland

Founded

1948-02-10

Risk Signals

21160 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., Drugs, Drug Proprietaries, and Druggists' Sundries), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Recent Articles about Novartis Pharma B.V.

Live alerts from global media, monitored by Business Radar

Gilead boosts US manufacturing amid Trump administration tariff, HIV healthcare challenges

2025-05-08 (emarketer.com)

Gilead boosts US manufacturing amid Trump administration tariff, HIV healthcare challenges

Gilead joins pharma companies that are boosting US manufacturing amid Trump-induced challenges: Gilead Sciences faces unique challenges as a leading HIV drugmaker—Trump's tariff threats coincide with cuts to global HIV programs and LGBTQ+ healthcare initiatives.

Read more
High operation on the euro airport due to Trump's customs duties: 747 are still flying to the USA quickly

2025-04-09 (bzbasel.ch)

High operation on the euro airport due to Trump's customs duties: 747 are still flying to the USA quickly

US President Donald Trump has announced further punitive tariffs for goods from abroad, sometimes they are already in force. The consequences are already noticeable.

Read more
Novartis teams up with Lindy Biosciences to improve biologic delivery

2024-08-29 (pharmaceutical-technology.com)

Novartis teams up with Lindy Biosciences to improve biologic delivery

Lindy Biosciences will receive a $20m upfront payment from Novartis and up to $934m in additional payments.

Read more
Novartis collaboration to innovate subcutaneous drug delivery

2024-08-29 (europeanpharmaceuticalreview.com)

Novartis collaboration to innovate subcutaneous drug delivery

The multi-target agreement could enhance treatment convenience by improving subcutaneous administration options for patients.

Read more
[Top Trends] Liposomes Drug Delivery Market

2024-06-24 (amore.ng)

[Top Trends] Liposomes Drug Delivery Market

[Top Trends] Liposomes Drug Delivery Market | S.p.A., Gilead Sciences, Novartis - Amoré

Read more
[Top Trends] Liposomes Drug Delivery Market

2024-06-24 (amore.ng)

[Top Trends] Liposomes Drug Delivery Market

[Top Trends] Liposomes Drug Delivery Market | S.p.A., Gilead Sciences, Novartis - Amoré

Read more
[Top Trends] Liposomes Drug Delivery Market

2024-06-24 (amore.ng)

[Top Trends] Liposomes Drug Delivery Market

[Top Trends] Liposomes Drug Delivery Market | S.p.A., Gilead Sciences, Novartis - Amoré

Read more
Liposomes Drug Delivery Market Size (Revenue)

2024-05-27 (amore.ng)

Liposomes Drug Delivery Market Size (Revenue)

Liposomes Drug Delivery Market Size (Revenue) | S.p.A., Gilead Sciences, Novartis - Amoré

Read more
Liposomes Drug Delivery Market Size (Revenue)

2024-05-27 (amore.ng)

Liposomes Drug Delivery Market Size (Revenue)

Liposomes Drug Delivery Market Size (Revenue) | S.p.A., Gilead Sciences, Novartis - Amoré

Read more
Liposomes Drug Delivery Market Size (Revenue)

2024-05-27 (amore.ng)

Liposomes Drug Delivery Market Size (Revenue)

Liposomes Drug Delivery Market Size (Revenue) | S.p.A., Gilead Sciences, Novartis - Amoré

Read more
Pluvicto Supply Shortage Update: What SNMMI is Doing

2023-03-16 (itnonline.com)

Pluvicto Supply Shortage Update: What SNMMI is Doing

March 16, 2023 — A supply problem with Pluvicto [177Lu-vipivotide tetraxetan; Novartis], the radiopharmaceutical used to treat metastatic prostate cancer, has led to shortages resulting in a delay of 3 months or longer for new patients, which is having a profound negative impact on patient care.

Read more
Press review from weekend 11 (March 11th/12th)

2023-03-12 (cash.ch)

Press review from weekend 11 (March 11th/12th)

Below is a selection of articles on business-related topics from the press over the weekend:

Read more

Never miss a headline about Novartis Pharma B.V.

Set up smart alerts with Business Radar and receive real-time updates on any new risk signal or major news story.

  • ✔️ Used by 100+ compliance teams and analysts
  • ✔️ Covers 154M+ sources in 40+ languages